Is MERS another SARS: The facts behind Middle East Respiratory Syndrome

August 24, 2015, American Society for Microbiology
MERS coronavirus particles (green) on camel epithelial cells. Credit: NIAID in collaboration with Colorado State University.

Experts show that while Middle East Respiratory Syndrome (MERS-CoV), a viral respiratory illness, is infecting less people, it has a higher mortality rate and affects a specific target population when compared to Severe Acute Respiratory Syndrome (SARS-CoV). This research is being presented at the International Conference on Emerging and Infectious Diseases in Atlanta, Georgia.

"The research conducted in this study focuses on understanding what population of individuals are most likely to become infected by MERS-CoV, compared to the infected by SARS-CoV," said Charis Royal from Arizona State University. Understanding the of the infected cases in both diseases can lead to understanding how the new disease will spread and if it can be compared to the SARS-CoV.

"An unusually high number of MERS-CoV cases are males with a of 50 years old, who have multiple chronic conditions," said Royal. " SARS-CoV, on the other hand, infects males and females nearly equally and both healthy and unhealthy individuals can be infected" she added. Both diseases spread rapidly in hospitals and hospital workers account for around 21% of infections in both SARS-CoV and MERS-CoV.

In 2003, multi-country outbreak of Severe Acute Respiratory Syndrome (SARS-CoV) left over 8000 people infected and had a death toll of over 700. In 2012, the novel coronavirus, MERS-CoV, which is related to SARS-CoV3, was first reported in Saudi Arabia. Over the last three years, MERS-CoV has spread to 14 different countries and infected more than 1300 individuals.

Data from the research was gathered through the World Health Organization summary reports for MERS-CoV and the cumulative data reports for the 2003 SARS-CoV outbreak.

Explore further: New compound inhibits enzyme crucial to MERS and SARS viruses, with a catch

More information: This research was presented as part of the 2015 International Conference on Emerging and Infectious Diseases held August 24 - 26 in Atlanta, Georgia.

Related Stories

New compound inhibits enzyme crucial to MERS and SARS viruses, with a catch

September 8, 2014
Scientists at the University of Illinois, Chicago, have identified a compound that effectively inhibits an enzyme crucial to the viruses that cause Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome ...

Oman reports first MERS death in nearly a year

January 8, 2015
Oman reported Thursday its first death of a person from Middle East Respiratory Syndrome coronavirus (MERS-CoV) in nearly a year.

SARS virus treatments could hold the key for treatment of MERS-CoV outbreak

September 13, 2013
A new type of coronavirus, the Middle East Respiratory Syndrome Coronavirus, MERS-CoV, was first found a year ago in a patient who died. It took several months before it was discovered that a new virus had emerged. New cases ...

Middle East respiratory syndrome: A global health challenge

June 17, 2015
The ongoing outbreak in the Republic of Korea (South Korea) is an important reminder that the Middle East respiratory virus (MERS-CoV) requires constant vigilance and could spread to other countries including the United States. ...

Middle East respiratory syndrome coronavirus has not yet reached pandemic potential

July 4, 2013
New estimates of the transmissibility of the Middle East respiratory syndrome coronavirus in humans suggest that it does not yet have pandemic potential, according to research published in The Lancet.

Double attack on SARS

August 28, 2012
After the SARS-CoV (severe acute respiratory syndrome coronavirus) outbreak in 2003, academia experts in immunology and molecular biology joined forces with industrial vaccine production experts in order to develop preventive ...

Recommended for you

Study identifies a key cellular mechanism that triggers pneumonia in humans

December 11, 2018
The relationship between influenza and pneumonia has long been observed by health workers. Its genetic and cellular mechanisms have now been investigated in depth by scientists in a study involving volunteers and conducted ...

Human antibody discovery could save lives from fungal killer

December 11, 2018
A new way to diagnose, treat and protect against stealth fungal infections that claim more than 1.5 million lives per year worldwide has been moved a step closer, according to research published in Nature Communications.

Effect of oral alfacalcidol on clinical outcomes in patients without secondary hyperparathyroidism

December 11, 2018
Treatment with active vitamin D did not decrease cardiovascular events in kidney patients undergoing hemodialysis, according to a research group in Japan. They have reported their research results in the December 11 issue ...

Dialysis patients at risk of progressive brain injury

December 10, 2018
Kidney dialysis can cause short-term 'cerebral stunning' and may be associated with progressive brain injury in those who receive the treatment for many years. For many patients with kidney failure awaiting a kidney transplant ...

Silicosis is on the rise, but is there a therapeutic target?

December 6, 2018
Researchers from the CNRS, the University of Orléans, and the company Artimmune, in collaboration with Turkish clinicians from Atatürk University, have identified a key mechanism of lung inflammation induced by silica exposure, ...

PET scans to optimize tuberculosis meningitis treatments and personalize care, study finds

December 6, 2018
Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain—or tuberculosis meningitis (TBM)—is often deadly, always hard to treat, and a particular ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.